Trajman A, Pai M, Dheda K, van Zyl Smit R, Zwerling A A, Joshi R, Kalantri S, Daley P, Menzies D
Pró-reitoria de Saúde, Gama Filho University, Rio de Janeiro, Brazil.
Eur Respir J. 2008 May;31(5):1098-106. doi: 10.1183/09031936.00147507.
Tuberculous pleuritis is a common manifestation of extrapulmonary tuberculosis and is the most common cause of pleural effusion in many countries. Conventional diagnostic tests, such as microscopic examination of the pleural fluid, biochemical tests, culture of pleural fluid, sputum or pleural tissue, and histopathological examination of pleural tissue, have known limitations. Due to these limitations, newer and more rapid diagnostic tests have been evaluated. In this review, the authors provide an overview of the performance of new diagnostic tests, including markers of specific and nonspecific immune response, nucleic acid amplification and detection, and predictive models based on combinations of markers. Directions for future development and evaluation of novel assays and biomarkers for pleural tuberculosis are also suggested.
结核性胸膜炎是肺外结核的常见表现,在许多国家是胸腔积液最常见的病因。传统的诊断方法,如胸腔积液显微镜检查、生化检查、胸腔积液、痰液或胸膜组织培养以及胸膜组织病理检查,都存在已知的局限性。由于这些局限性,人们对更新、更快速的诊断方法进行了评估。在这篇综述中,作者概述了新诊断方法的性能,包括特异性和非特异性免疫反应标志物、核酸扩增和检测,以及基于标志物组合的预测模型。还提出了未来胸膜结核新检测方法和生物标志物的开发与评估方向。